Replies to post #8470 on Biostax Corp (BTAX)

[Hopeful1037]

All kinds of possibilities. Just takes a long long time for a small bio firm to get out in front of the fda realities. We are on our we been on our Just. Getting slapped. Around by the short.s. Who would love nothing then us going to. Zero. Well guess what. I don’t think soooooo

[H1C]

she says it works well with no side effects.

That's the best thing about LDN, imo: there's no downside to trying it. Even if it doesn't work for you -- and no medication will work for everyone -- LDN has one of the most benign side-effect profiles of any medication. It essentially has no side effects.

And yes, I agree that all it would take is an approval by the FDA for one indication, and the floodgates would open in the US for its use.

Doctors are by training conservative and by-and-large not outside-the-box thinkers. Medical training is mostly rote memorization, and in our litigious climate, they are punished for straying outside the 'standard of care.' And who decides the 'standard of care'? CMS and the commercial insurers, for the most part, and also the professional specialty boards. And who whispers most into the ears of of all three? Big pharma.

I'm not saying big pharma dictates everything that doctors do in how they treat patients, but they play a massive, outsized role, sometimes with dubious (at best) evidence to back up their recommendations which make their way into the standard of care. The prime example of this is the extreme overuse of statins in the US and UK. Statins are a poison that very few, if any, people should be on, yet they are the most prescribed and most successful prescription drug class in history. By far.

All it would take is for LDN to have one FDA approved indication. Once doctors, and especially CMS and the insurers, understood LDN's mechanism of action -- that it switches inflammatory cytokines to non-inflammatory, and that it up-regulates endorphins and other immune system components -- I think we'd see tons of off-label prescribing. Especially given LDN's favorable side-effect profile and its low cost.

Right now, without the FDA approval, it's only the outside-the-box type doctors who are willing even to look into LDN and give it a try. They are in the tiny minority. It took months of my talking about it, and sharing links with the clinicians where I work, for them to try it out. But now that they're getting positive reports back from patients, they're fully on-board with it.